欧洲药典适用性证书数据库（欧盟CEP认证）

专论编号	物质名称	证书持有人	持有人ORG-ID和LOC-ID	证书编号	发布日期	证书状态	证书结束日期	证书类型	上一程序的结束日期	历史数据程序类型\|结论\|日期
2338	Mirtazapine	TAPI NL B.V. Amsterdam NL	100003852;100094134	CEP 2008-141 - Rev 04	2025/07/16	Valid		Chemical	2025/07/16	Notification\|CEP granted\|16/07/2025; Minor revision\|Accepted - CEP remains valid\|05/04/2024; Notification\|CEP granted\|21/12/2021; Minor revision\|CEP granted\|03/04/2020
2119	Venlafaxine hydrochloride	TAPI NL B.V. Amsterdam NL	100003852;100094134	CEP 2007-297 - Rev 07	2025/07/15	Valid		Chemical	2025/07/15	Notification\|CEP granted\|15/07/2025; Minor revision\|CEP granted\|22/03/2024; Notification\|CEP granted\|04/02/2022; Notification\|CEP granted\|11/08/2021
1694	Gemfibrozil	TAPI NL B.V. Amsterdam NL	100003852;100094134	CEP 2006-210 - Rev 06	2025/07/15	Valid		Chemical	2025/07/15	Notification\|CEP granted\|15/07/2025; Notification\|CEP granted\|05/01/2022; Minor revision\|CEP granted\|16/10/2020
391	Furosemide	TAPI NL B.V. Amsterdam NL	100003852;100094134	CEP 1997-019 - Rev 10	2025/07/15	Valid		Chemical	2025/07/15	Notification\|CEP granted\|15/07/2025; Notification\|Accepted - CEP remains valid\|24/08/2022; Notification\|CEP granted\|20/12/2021; Minor revision\|CEP granted\|09/09/2020
712	Desmopressin	TAPI NL B.V. Amsterdam NL	100003852;100094134	CEP 2006-113 - Rev 04	2025/07/15	Valid		Chemical	2025/07/25	Notification\|Accepted - CEP remains valid\|25/07/2025; Notification\|CEP granted\|15/07/2025; Minor revision\|Accepted - CEP remains valid\|17/02/2023; Minor revision\|CEP granted\|07/10/2021; Minor revision\|CEP granted\|09/03/2020
2173	Gabapentin	TAPI NL B.V. Amsterdam NL	100003852;100094134	CEP 2011-167 - Rev 03	2025/07/15	Valid		Chemical	2025/07/15	Notification\|CEP granted\|15/07/2025; Notification\|CEP granted\|23/02/2022
2191	Atorvastatin calcium, AS	TAPI NL B.V. Amsterdam NL	100003852;100094134	CEP 2018-059 - Rev 01	2025/07/15	Valid		Chemical	2025/07/15	Minor revision\|CEP granted\|15/07/2025; Notification\|Accepted - CEP remains valid\|01/03/2024; Renewal\|CEP granted\|30/06/2023; Monograph revision\|CEP granted\|18/08/2022; Notification\|CEP granted\|04/01/2022
2011	Calcipotriol	FORMOSA LABORATORIES, INC. Taoyuan TW	100011879;100018688	CEP 2007-243 - Rev 02	2025/07/15	Valid		Chemical	2025/07/15	Minor revision\|CEP granted\|15/07/2025; Notification\|Rejected\|24/03/2025; Notification\|Accepted - CEP remains valid\|05/11/2020
1765	Salmeterol xinafoate, Micronised	FARMABIOS S.p.A Gropello Cairoli IT	100011643;100021232	CEP 2018-168 - Rev 01	2025/07/15	Valid		Chemical	2025/07/15	Renewal\|CEP granted\|15/07/2025
576	Allopurinol	TAPI NL B.V. Amsterdam NL	100003852;100094134	CEP 1998-118 - Rev 08	2025/07/11	Valid		Chemical	2025/07/11	Notification\|CEP granted\|11/07/2025; Notification\|CEP granted\|20/12/2021; Minor revision\|Accepted - CEP remains valid\|15/03/2021
1028	Metoprolol tartrate	TAPI NL B.V. Amsterdam NL	100003852;100094134	CEP 2001-240 - Rev 04	2025/07/11	Valid		Chemical	2025/07/11	Notification\|CEP granted\|11/07/2025; Minor revision\|Accepted - CEP remains valid\|22/09/2023; Notification\|CEP granted\|04/02/2022
253	Ascorbic acid	DSM-FIRMENICH SWITZERLAND AG Kaiseraugst CH	100053293;100094111	CEP 1996-078 - Rev 06	2025/07/11	Valid		Chemical	2025/07/11	Notification\|CEP granted\|11/07/2025; Monograph revision\|Accepted - CEP remains valid\|13/07/2023; Minor revision\|CEP granted\|04/10/2022
1651	Clarithromycin	TAPI NL B.V. Amsterdam NL	100003852;100094134	CEP 2004-114 - Rev 05	2025/07/11	Valid		Chemical	2025/07/11	Notification\|CEP granted\|11/07/2025; Minor revision\|Accepted - CEP remains valid\|19/03/2024; Notification\|CEP granted\|05/01/2022; Notification\|Accepted - CEP remains valid\|19/10/2021
807	Ascorbyl palmitate	DSM-FIRMENICH SWITZERLAND AG Kaiseraugst CH	100053293;100094111	CEP 2002-255 - Rev 01	2025/07/11	Withdrawn by Holder	2025/09/02	Chemical	2025/07/11
1073	Biotin	DSM-FIRMENICH SWITZERLAND AG Kaiseraugst CH	100053293;100094111	CEP 2001-405 - Rev 07	2025/07/11	Valid		Chemical	2025/07/11	Notification\|CEP granted\|11/07/2025; Minor revision\|CEP granted\|22/04/2024; Minor revision\|CEP granted\|16/01/2023; Minor revision\|CEP granted\|02/02/2022
1706	Thiamazole	CU CHEMIE UETIKON GMBH Lahr DE	100012598;100021471	CEP 2008-293 - Rev 02	2025/07/11	Valid		Chemical	2025/07/11	Monograph revision\|CEP granted\|11/07/2025; Minor revision\|CEP granted\|04/12/2023
2296	Pantoprazole sodium sesquihydrate	TAPI NL B.V. Amsterdam NL	100003852;100094134	CEP 2009-302 - Rev 04	2025/07/11	Valid		Chemical	2025/07/11	Notification\|CEP granted\|11/07/2025; Minor revision\|Accepted - CEP remains valid\|10/07/2024; Notification\|CEP granted\|21/12/2021; Minor revision\|CEP granted\|08/06/2021
2219	Lansoprazole	TAPI NL B.V. Amsterdam NL	100003852;100094134	CEP 2009-301 - Rev 05	2025/07/11	Valid		Chemical	2025/07/11	Notification\|CEP granted\|11/07/2025; Minor revision\|CEP granted\|05/04/2024; Notification\|CEP granted\|10/03/2022; Notification\|CEP granted\|20/12/2021; Minor revision\|Accepted - CEP remains valid\|11/12/2020
2404	Drospirenone	TAPI NL B.V. Amsterdam NL	100003852;100094134	CEP 2010-014 - Rev 02	2025/07/11	Valid		Chemical	2025/07/11	Notification\|CEP granted\|11/07/2025; Minor revision\|Accepted - CEP remains valid\|20/08/2024; Minor revision\|Accepted - CEP remains valid\|16/11/2023; Minor revision\|Accepted - CEP remains valid\|13/02/2023; Notification\|CEP granted\|04/01/2022
470	Calcium Pantothenate	DSM-FIRMENICH SWITZERLAND AG Kaiseraugst CH	100053293;100094111	CEP 2004-267 - Rev 03	2025/07/11	Valid		Chemical	2025/07/11	Notification\|CEP granted\|11/07/2025; Minor revision\|Accepted - CEP remains valid\|21/07/2021; Monograph revision\|Accepted - CEP remains valid\|16/04/2021

专论编号 (Monograph Number)
物质名称 (Substance)
证书持有人 (Certificate (CEP) Holder)
证书编号 (Certificate (CEP) Number)
证书类型 (Type CEP)
证书状态 (Status CEP)
发布日期(Issue Date CEP)	-
证书效期(End date CEP)	-